Oral budesonide in the treatment of chronic refractory pouchitis

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 10, 2007, Pages 1231-1236

  Gionchetti, P ^a,b   Rizzello, F ^b   Poggioli, G ^b   Pierangeli, F ^b   Laureti, S ^b   Morselli, C ^b   Tambasco, R ^b   Calabrese, C ^b   Campieri, M ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CIPROFLOXACIN; ENTOCIR; METRONIDAZOLE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; INTESTINE ENDOSCOPY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BUDESONIDE; CHRONIC DISEASE; COLITIS, ULCERATIVE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POUCHITIS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 34247465218     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03306.x     Document Type: Article

References (24)

1. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994 107 : 1856 60.
2. Svaninger G, Nordgren S, Oresland T, Hulten L. Incidence and characteristics of pouchitis in the Koch continent ileostomy and the pelvic pouch. Scand J Gastroenterol 1993 28 : 695 700.
3. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996 38 : 234 9.
4. Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996 39 : 1012 8.
5. Meagher AP, Farouk R, Dozois R, Kelly KA, Pemberton JH. J-ileal pouch-anal anastomosis for CUC: complications and long-term outcome in 1310 patients. Br J Surg 1998 85 : 800 3.
6. Fazio VW, O'Riordain MG, Lavery IC, et al. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg 1999 230 : 575 84.
7. Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000 24 : 851 6.
8. Sandborn WJ. Pouchitis: definition, risk factors, frequency, natural history, classification, and public perspectives. In : McLeod RS, Martin F, Sutherland LR, Wallace JL, Williams CN, eds. Trends in Inflammatory Bowel Disease 1996, Lancaster, UK : Kluwer Academic Publishers, 1997 : 51 63.
9. Sheperd NA, Jass JR, Duval I, Moskowitz RL, Nicholls RJ, Morson BC. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy. J Clin Pathol 1987 40 : 601 7.
10. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994 69 : 409 15.
11. Madden M, McIntyre A, Nicholls RJ. Double blind cross-over trial of metronidazole vs. placebo in chronic unremitting pouchitis. Dig Dis Sci 1994 39 : 1193 6.
12. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999 13 : 713 8.
13. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001 7 : 301 5.
14. Mimura T, Rizzello F, Helwig U, et al. Four week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002 16 : 909 17.
15. Sheperd NA, Hulten L, Tytgat GN, et al. Pouchitis. Int J Colorectal Dis 1989 4 : 205 29.
16. Tytgat GN, van deventer SJ. Pouchitis. Int J Colorectal Dis 1988 3 : 226 8.
17. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994 331 : 836 41.
18. Rutgeerts P, Lofberg R, Helmut M, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994 331 : 842 5.
19. Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis. A double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther 2002 16 : 27 34.
20. Chopra A, Pardi DS, Loftus EV, et al. Budesonide in the treatment of Inflammatory Bowel Disease: the first year of experience in clinical practice. Inflamm Bowel Dis 2006 12 : 29 32.
21. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989 96 : 804 10.
22. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol Ther 2006 23 : 1087 96.
23. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 : 305 9.
24. Miner P Jr., Wedel M, Bane B, Bradley J. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis. Aliment Pharmacol Ther 2004 19 : 281 6.